FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.675,68 +450,02 (+1,18%) Nasdaq
16.156,33 +315,37 (+1,99%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
77,99 -0,96 (-1,22%) Bitcoin EUR
59.458,79 +1.845,80 (+3,20%)
LFST Jan 2025 10.000 put
| Chiusura precedente | 3,9000 |
| Aperto | 3,9000 |
| Denaro | 3,1000 |
| Lettera | 4,5000 |
| Prezzo d'esercizio | 10,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 3,9000 - 3,9000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 263 |
GlobeNewswireLifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors Conference
SCOTTSDALE, Ariz., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 7th Annual Bernstein Healthcare Services Disruptors Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenter: Dave Bourdon, CFODate: Wednesday, October 4, 2023 Time: 8:30 a.m. (Eastern time)Moderated by: Lance Wilkes
- GlobeNewswire
LifeStance to Present at the 21st Annual Morgan Stanley Healthcare Conference
SCOTTSDALE, Ariz., Aug. 28, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 21st Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenters: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor RelationsDate: Monday, September 11, 2023 Time
- GlobeNewswire
LifeStance Reports Second Quarter 2023 Results
SCOTTSDALE, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2023. (All results compared to prior-year comparative period, unless otherwise noted)Q2 2023 Highlights and FY 2023 Outlook Total revenue of $259.6 million increased $50.1 million or 24% compared to total revenue of $209.5 millionTotal clinicians of 6,132 up
